Arrowhead Pharmaceuticals (ARWR) Q2 2025 Earnings

12MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-1.39
-0.01
1.37
2.75

Details

Expected EPS
-0.187367
Actual EPS
2.75
Surprise EPS
2.94
Surprise Percent
+1,567.71%

Description

Arrowhead Pharmaceuticals (ARWR) has reported earnings of 2.75 per share for Q2 2025.

0 Comments

Share your thoughts